Prophage vitespen: Preliminary Phase II data

Preliminary data from a single-arm, U.S. Phase II trial in 46 patients with newly diagnosed GMB showed that intradermal Prophage G-100 plus standard of care (SOC) radiation and temozolomide led to a m...